SCHEMBL7220175

SCHEMBL7220175

[CH2]c1ccc2nnn(O)c2c1

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.53
MAPK1 P28482 1/20 0.53
ATM Q13315 1/20 0.53
ALDH1A1 P00352 2/20 0.45
PKM P14618 1/20 0.43
HSD17B10 Q99714 1/20 0.38
KDM4E B2RXH2 1/20 0.37
DGAT1 O75907 1/20 0.36
CTNNB1 P35222 9/20 0.36
TCF7L2 Q9NQB0 1/20 0.35
SLC9A1 P19634 1/20 0.31
KEAP1 Q14145 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP3A4 P08684 1/20 0.31
CYP2D6 P10635 1/20 0.31
MAPT P10636 1/20 0.31
CYP2C9 P11712 1/20 0.31
THPO P40225 1/20 0.31
CYP4Z1 Q86W10 1/20 0.31
CYP19A1 P11511 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18724699 0.73 POLB (0.50) POLBMAPK1ATMALDH1A1PKM
SCHEMBL3672275 0.70 POLB (1.00) POLBMAPK1ATMALDH1A1PKM
SCHEMBL3279018 0.68 PKM (0.47) POLBMAPK1ATMALDH1A1PKM
SCHEMBL4594947 0.68 POLB (0.44) POLBMAPK1ATMALDH1A1PKM
SCHEMBL875075 0.68 POLB (0.95) POLBMAPK1ATMALDH1A1PKM
Hydrochloric Acid SCHEMBL3033535 0.68 POLB (0.95) POLBMAPK1ATMALDH1A1PKM
SCHEMBL7424280 0.68 POLB (0.95) POLBMAPK1ATMALDH1A1PKM
SCHEMBL3033056 0.68 POLB (0.95) POLBMAPK1ATMALDH1A1PKM
Water SCHEMBL134510 0.68 POLB (0.95) POLBMAPK1ATMALDH1A1PKM
Water SCHEMBL1915155 0.68 POLB (0.95) POLBMAPK1ATMALDH1A1PKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6503898-B1 Administering 4,7-dibenzyl-5,6-dihydroxy-N,N*-di(m-aminobenzyl)--1,3-diazepin-2-one or salt to treat human immunodeficiency virus infection BRISTOL-MYERS SQUIBB PHARMA COMPANY 2003-01-07 US disclosed